See also this year's filing and all EDGAR filings for this company.
PDF Report 0001832415_2022_Better_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | No stock price available | subcommand.plot | {} |
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001832415')"} |
Graph
Absolute values for 0001832415, Better Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 0 |
| 1 | AssetsNonCurrent | 548,000 |
| 2 | AssetsCurrent | 45,251,000 |
| 3 | PropertyPlantAndEquipment | 82,000 |
| 4 | remainder_Assets | 5,077,000 |
| 5 | LongTermLiabilities | 9,505,000 |
| 6 | LiabilitiesCurrent | 4,733,000 |
| 7 | remainder_Liabilities | 0 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 0 |
| 10 | GeneralAndAdministrativeExpense | 8,788,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 2,336,000 |
| 15 | ResearchAndDevelopmentExpense | 19,436,000 |
| 16 | remainder_Expenses | 679,000 |
| 17 | remainder_Revenues | 0 |
| 18 | remainder_NetIncome | -10,390,000 |
| 19 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 50,958,000 |
| 1 | Liabilities | 14,238,000 |
| 2 | Expenses | 31,239,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 36,720,000 |
| 5 | NetIncome | -41,629,000 |
| 6 | ComprehensiveNetIncome | -41,629,000 |
| 7 | BaseVar | 53,412,500 |
| 8 | EconomicCapitalRatio | 1.85 |
Edgar->Model Mapping
Feature Distribution
